North America Radioimmunoassay Market Analysis, Demand & Growth Forecast

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA RADIOIMMUNOASSAY MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET TESTING TYPE COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTYER’S FIVE FORCES

4.3 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS

5 INDUSTRY INSIGHTS:

6 REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY

6.1 U.S REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY

6.2 EUROPE REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY

6.3 INDIA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY

6.4 CHINA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASE IN THE DEMAND FOR ERROR-FREE AND ACCURATE RESULTS OF HIGH THROUGHPUT AND AUTOMATED PROCEDURES

7.1.2 RISE IN THE PREVALENCE AND INCIDENCE OF INFECTIOUS DISEASES

7.1.3 RISE IN THE TECHNOLOGICAL ADVANCEMENTS

7.2 RESTRAINTS

7.2.1 HIGH COST OF INSTALLATION AND MAINTENANCE OF RADIOIMMUNOASSAY KITS

7.2.2 SHORT SHELF-LIFE OF RADIOLABELED COMPOUNDS

7.2.3 ADVERSE EFFECTS OF HAZARDOUS RADIOACTIVE ELEMENTS

7.3 OPPORTUNITIES

7.3.1 INCREASING SIGNIFICANCE OF RESEARCH AND DEVELOPMENT IN MEDICAL SCIENCE

7.3.2 RISE IN GOVERNMENT FUNDING AND OVERALL HEALTHCARE EXPENDITURE

7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS

7.4 CHALLENGES

7.4.1 LACK OF SKILLED PROFESSIONALS

7.4.2 NEW INNOVATIONS IN VARIOUS OTHER IMMUNOASSAY PROCEDURES

8 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE

8.1 OVERVIEW

8.2 RADIOIMMUNOASSAY REAGENTS AND KITS

8.2.1 KITS

8.2.2 BUFFER

8.2.2.1 SOLUTION

8.2.2.2 POWDER

8.2.3 STANDARD CONCENTRATES

8.2.4 PRECIPITATING REAGENTS

8.2.5 RADIOISOTOPES

8.2.5.1 BETA EMITTERS

8.2.5.1.1 TRITIUM

8.2.5.1.2 CARBON-14

8.2.5.2 GAMMA EMITTERS

8.2.5.2.1 IODINE-125

8.2.5.2.2 CHROMIUM-51

8.2.5.2.3 COBALT-57

8.2.6 ANTIBODY/ANTISERUM

8.2.6.1 POLYCLONAL

8.2.6.2 MONOCLONAL

8.2.7 OTHERS

8.3 RADIOIMMUNOASSAY ANALYZER

9 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY APPLICATION

9.1 OVERVIEW

9.2 SCIENTIFIC RESEARCH

9.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS

9.2.2 RADIOIMMUNOASSAY ANALYZER

9.3 CLINICAL DIAGNOSIS

9.3.1 INFECTIOUS DISEASE TESTING

9.3.1.1 RADIOIMMUNOASSAY REAGENTS AND KITS

9.3.1.2 RADIOIMMUNOASSAY ANALYZER

9.3.2 ALLERGY TESTING

9.3.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS

9.3.2.2 RADIOIMMUNOASSAY ANALYZER

9.3.3 ONCOLOGY TESTING

9.3.3.1 RADIOIMMUNOASSAY REAGENTS AND KITS

9.3.3.2 RADIOIMMUNOASSAY ANALYZER

9.3.4 ENDOCRINE TESTING

9.3.4.1 RADIOIMMUNOASSAY REAGENTS AND KITS

9.3.4.2 RADIOIMMUNOASSAY ANALYZER

9.3.5 TOXICOLOGY TESTING

9.3.5.1 RADIOIMMUNOASSAY REAGENTS AND KITS

9.3.5.2 RADIOIMMUNOASSAY ANALYZER

9.3.6 AUTOIMMUNE DISEASE TESTING

9.3.6.1 RADIOIMMUNOASSAY REAGENTS AND KITS

9.3.6.2 RADIOIMMUNOASSAY ANALYZER

9.3.7 OTHER DISEASE TESTING

10 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.3 CLINICAL DIAGNOSTIC LABORATORIES

10.4 ACADEMIC AND RESEARCH INSTITUTES

10.5 PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY

10.6 CONTRACT RESEARCH ORGANISATIONS

10.7 OTHERS

11 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 DIRECT TENDER

11.3 ONLINE SALES

11.4 THIRD PARTY DISTRIBUTIONS

11.5 OTHERS

12 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY REGION

12.1 NORTH AMERICA

12.1.1 U.S.

12.1.2 CANADA

12.1.3 MEXICO

13 NORTH AMERICA RADIOIMMUNOASSAY MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

14 SWOT ANALYSIS

15 COMPANY PROFILE

15.1 PERKINELMER INC.

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.4 RECENT DEVELOPMENT

15.2 MERCK KGAA

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENTS

15.3 BECKMAN COULTER, INC.

15.3.1 COMPANY SNAPSHOT

15.3.2 COMPANY SHARE ANALYSIS

15.3.3 PRODUCT PORTFOLIO

15.3.4 RECENT DEVELOPMENT

15.4 ABCAM PLC

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENT

15.5 TECAN TRADING AG

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 COMPANY SHARE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENT

15.6 BERTHOLD TECHNOLOGIES GMBH & CO.KG

15.6.1 COMPANY SNAPSHOT

15.6.2 PRODUCT PORTFOLIO

15.6.3 RECENT DEVELOPMENTS

15.7 DEMEDITEC DIAGNOSTICS GMBH

15.7.1 COMPANY SNAPSHOT

15.7.2 PRODUCT PORTFOLIO

15.7.3 RECENT DEVELOPMENTS

15.8 DIASOURCE

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENT

15.9 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENTS

15.1 HIDEX OY

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENTS

15.11 IMMUNO-BIOLOGICAL LABORATORIES CO,LTD.

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENT

15.12 INSTITUTE OF ISOTOPES

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENTS

15.13 KAMIYA BIOMEDICAL COMPANY

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENTS

15.14 MP BIOMEDICALS

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENTS

15.15 MYBIOSOURCE.COM.

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

List of Table

TABLE 1 LIST OF IN-VITRO DIAGNOSTIC MEDICAL DEVICES (IVD ANALYZERS) UNDER PROVISIONS OF SUB-RULE (2) RULE 4 OF THE MEDICAL DEVICES RULES, 2017

TABLE 2 COST OF RIA KITS IS MENTIONED BELOW

TABLE 3 DECOMPOSITION RATES OF A FEW RADIOLABELED ISOTOPES ARE MENTIONED IN THE BELOW TABLE

TABLE 4 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 5 NORTH AMERICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 6 NORTH AMERICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 7 NORTH AMERICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 8 NORTH AMERICA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 9 NORTH AMERICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 10 NORTH AMERICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 11 NORTH AMERICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 12 NORTH AMERICA RADIOIMMUNOASSAY ANALYZER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 13 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 14 NORTH AMERICA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 15 NORTH AMERICA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 16 NORTH AMERICA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 17 NORTH AMERICA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 18 NORTH AMERICA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 19 NORTH AMERICA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 20 NORTH AMERICA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 21 NORTH AMERICA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 22 NORTH AMERICA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)

TABLE 23 NORTH AMERICA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 24 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 25 NORTH AMERICA HOSPITALS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 26 NORTH AMERICA CLINICAL DIAGNOSTIC LABORATORIES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 27 NORTH AMERICA ACADEMIC AND RESEARCH INSTITUTES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 28 NORTH AMERICA PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 29 NORTH AMERICA CONTRACT RESEARCH ORGANISATIONS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 30 NORTH AMERICA OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 31 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 32 NORTH AMERICA DIRECT TENDER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 33 NORTH AMERICA ONLINE SALES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 34 NORTH AMERICA THIRD PARTY DISTRIBUTION IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 35 NORTH AMERICA OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 36 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 37 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 38 NORTH AMERICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 39 NORTH AMERICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 40 NORTH AMERICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 41 NORTH AMERICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 42 NORTH AMERICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 43 NORTH AMERICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 44 NORTH AMERICA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 45 NORTH AMERICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 46 NORTH AMERICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 47 NORTH AMERICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 48 NORTH AMERICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 49 NORTH AMERICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 50 NORTH AMERICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 51 NORTH AMERICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)

TABLE 52 NORTH AMERICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)

TABLE 53 NORTH AMERICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)

TABLE 54 NORTH AMERICA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 55 NORTH AMERICA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 56 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 57 NORTH AMERICA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 58 NORTH AMERICA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 59 NORTH AMERICA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 60 NORTH AMERICA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 61 NORTH AMERICA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 62 NORTH AMERICA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 63 NORTH AMERICA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)

TABLE 64 NORTH AMERICA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 65 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 66 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 67 U.S. RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 68 U.S. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 69 U.S. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 70 U.S. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 71 U.S. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 72 U.S. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 73 U.S. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 74 U.S. RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 75 U.S. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 76 U.S. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 77 U.S. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 78 U.S. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 79 U.S. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 80 U.S. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 81 U.S. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)

TABLE 82 U.S. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)

TABLE 83 U.S. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)

TABLE 84 U.S. RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 85 U.S. RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 86 U.S. RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 87 U.S. SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 88 U.S. CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 89 U.S. INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 90 U.S. ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 91 U.S. ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 92 U.S. ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 93 U.S. TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)

TABLE 94 U.S. AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 95 U.S. RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 96 U.S. RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 97 CANADA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 98 CANADA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 99 CANADA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 100 CANADA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 101 CANADA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 102 CANADA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 103 CANADA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 104 CANADA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 105 CANADA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 106 CANADA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 107 CANADA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 108 CANADA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 109 CANADA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 110 CANADA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 111 CANADA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)

TABLE 112 CANADA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)

TABLE 113 CANADA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)

TABLE 114 CANADA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 115 CANADA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 116 CANADA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 117 CANADA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 118 CANADA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 119 CANADA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 120 CANADA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 121 CANADA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 122 CANADA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 123 CANADA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)

TABLE 124 CANADA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 125 CANADA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 126 CANADA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 127 MEXICO RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 128 MEXICO RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 129 MEXICO RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 130 MEXICO RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 131 MEXICO BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 132 MEXICO BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 133 MEXICO BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 134 MEXICO RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 135 MEXICO BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 136 MEXICO BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 137 MEXICO BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 138 MEXICO GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 139 MEXICO GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 140 MEXICO GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 141 MEXICO ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)

TABLE 142 MEXICO ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)

TABLE 143 MEXICO ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)

TABLE 144 MEXICO RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 145 MEXICO RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 146 MEXICO RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 147 MEXICO SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 148 MEXICO CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 149 MEXICO INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 150 MEXICO ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 151 MEXICO ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 152 MEXICO ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 153 MEXICO TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)

TABLE 154 MEXICO AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 155 MEXICO RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 156 MEXICO RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

List of Figure

FIGURE 1 NORTH AMERICA RADIOIMMUNOASSAY MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA RADIOIMMUNOASSAY MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA RADIOIMMUNOASSAY MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA RADIOIMMUNOASSAY MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA RADIOIMMUNOASSAY: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA RADIOIMMUNOASSAY MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA RADIOIMMUNOASSAY MARKET: DBMR MARKET POSITION GRID

FIGURE 8 NORTH AMERICA RADIOIMMUNOASSAY MARKET: MARKET TESTING TYPE COVERAGE GRID

FIGURE 9 NORTH AMERICA RADIOIMMUNOASSAY MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA RADIOIMMUNOASSAY MARKET: SEGMENTATION

FIGURE 11 RISING PREVALENCE AND INCIDENCE OF INFECTIOUS DISEASES ARE EXPECTED TO DRIVE THE NORTH AMERICA RADIOIMMUNOASSAY MARKET IN THE FORECAST PERIOD

FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA RADIOIMMUNOASSAY MARKET IN 2023 & 2030

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA RADIOIMMUNOASSAY MARKET

FIGURE 14 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, 2022

FIGURE 15 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)

FIGURE 16 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, CAGR (2023-2030)

FIGURE 17 NORTH AMERICA RADIOIMMUNOASSAY MARKET: PRODUCT TYPE, LIFELINE CURVE

FIGURE 18 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY APPLICATION, 2022

FIGURE 19 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 20 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 21 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 22 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY END USER, 2022

FIGURE 23 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 24 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY END USER, CAGR (2023-2030)

FIGURE 25 NORTH AMERICA RADIOIMMUNOASSAY MARKET : BY END USER, LIFELINE CURVE

FIGURE 26 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 27 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 28 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 29 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 30 NORTH AMERICA RADIOIMMUNOASSAY MARKET: SNAPSHOT (2022)

FIGURE 31 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022)

FIGURE 32 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY COUNTRY (2023 & 2030)

FIGURE 33 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022 & 2030)

FIGURE 34 NORTH AMERICA RADIOIMMUNOASSAY MARKET: PRODUCT TYPE (2023-2030)

FIGURE 35 NORTH AMERICA RADIOIMMUNOASSAY MARKET: COMPANY SHARE 2022 (%)

Frequently Asked Questions

At what growth rate will the market be projected to grow during the forecast period of 2023 to 2030?

The North America Radioimmunoassay Market is projected to grow at a CAGR of 4.4% during the forecast period by 2030.

What will be the market value in the future?

The future market value of the North America Radioimmunoassay Market is expected to reach USD 407.2 million by 2030.

Who are the major players operating in the market?

The major players in the North America Radioimmunoassay Market are PerkinElmer Inc., KAMIYA BIOMEDICAL COMPANY, Beckman Coulter, Inc., and Abcam plc. MyBioSource.com., and MP BIOMEDICALS, etc.

Which countries data are covered in the report?

The countries covered in the North America Radioimmunoassay Market are U.S., Canada, and Mexico.